Recomendaciones de uso de everolimus en el trasplante hepático

Autor: Itxarone Bilbao Aguirre, Evaristo Varo Pérez, Angel Rubín Suárez, Magdalena Salcedo Plaza, Javier Fernández-Castroagudín, José Antonio Pons Miñano, Martín Prieto Castillo

Publikováno v: Gastroenterología y Hepatología. 40:629-640

Resumen Los farmacos inhibidores de la mTOR, everolimus (EVL) y sirolimus, son inmunosupresores con muy poco efecto nefrotoxico, limitado al desarrollo de proteinuria en algunos casos. En la prevencion del rechazo agudo EVL combinado con tacrolimus a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f5f4281fde5534a73c0d84fd42f0b794
https://doi.org/10.1016/j.gastrohep.2017.05.008

The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study

Autor: Esther Molina-Pérez, Maria Varela, Nora Otegui, María Isabel Monge-Romero, Lluis Castells, Manuel de la Mata, José Eduardo Rodríguez-Menéndez, Juan Turnes, Iratxe Díez-Miranda, Javier Irurzun, Maria Pipa-Muñiz, María Senosiaín, Javier Bustamante-Schneider, Sonia Pascual, Daniel Pérez-Enguix, Juan Arenas, Roberto Díaz-Beveridge, Javier Fernández-Castroagudín

Publikováno v: GASTROENTEROLOGIA Y HEPATOLOGIA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Introduction: The appropriate selection of hepatocellular carcinoma (HCC) patients who are eligible for transarterial chemoembolization (TACE) remains a challenge. The ART score has recently been proposed as a method of identifying patients who are e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7711f0418fbfdbe48aeda60ef5f830b4
https://doi.org/10.1016/j.gastre.2017.05.007

Differences in the Incidence and Clinical Evolution of Early Neurotoxicity After Liver Transplantation Based on Tacrolimus Formulation Used in the Immunosuppressive Induction Protocol

Autor: J. Martínez-Castro, Evaristo Varo-Pérez, Esteban Otero-Antón, A. Fernández Pérez, Esther Molina-Pérez, R. Souto-Rodríguez, Javier Fernández Castroagudín, S. Tomé Martínez de Rituerto

Publikováno v: RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)

Posttransplant early calcineurin inhibitor (CNI)-induced neurotoxicity (ECIIN) was related to high CNI levels, among other factors. Minimizing exposure could modify its incidence or clinical evolution.To compare the incidence, predisposing factors, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef8c3ef8304d03bb71bebd7c7d76a6a
https://doi.org/10.1016/j.transproceed.2014.10.006

Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction

Autor: Javier Fernández Castroagudín, Esteban Otero, E. Varo Pérez, Santiago Tomé, E. Molina, L. Vizcaíno, C. Ponton, A. López-Lago

Publikováno v: Transplantation Proceedings. 42:656-659

Calcineurin inhibitors (CNI) are the main pathogenic factors for renal dysfunction in solid organ transplant recipients. Introduction of non-nephrotoxic immunosuppressive drugs, such as mycophenolate mofetil (MMF), may allow discontinuation or reduct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a87070660f1332c6aa2ea951d72f2307
https://doi.org/10.1016/j.transproceed.2010.02.006

Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC) Colangitis y abscesos hepáticos múltiples tras la inyección percutánea de etanol (IPE) en el tratamiento del carcinoma hepatocelular recurrente

Autor: Fernando Macias-García, Nicolau Vallejo-Senra, Sandra Baleato-González, Javier Fernández-Castroagudín, Esther Molina-Pérez, J. Enrique Domínguez-Muñoz

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 105, Iss 2, Pp 110-112 (2013)

Percutaneous ablation procedures are minimally invasive treatments for unresectable early stage hepatocellular carcinoma (HCC). These techniques are usually safe, but rare and even fatal complications have been described. We present a fatal result af

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::75a5db7babf6791a4794433136e6bef3
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082013000200010